The 2-(4Ј-aminophenyl)-6-methylbenzothiazole that is known to display affinity and specificity toward the amyloid plaques of Alzheimer's disease (AD) has been joined to the tricarbonyl [M(CO) 3 NNO] chelate (M = Re, 99 Tc, and 99m Tc) through a five-carbon linker chain to generate the neutral complex 1 (namely, Re-1 for M = Re; 99 Tc-1 for M = 99 Tc; and 99m Tc-1 for M = 99m Tc) with the aim of developing a singlephoton emission computed tomography (SPECT) radiodiagnostic agent for AD. Re-1 was characterized by spectroscopic methods and X-ray crystallography, whereas the detailed4279 NMR spectroscopic analysis of 99 Tc-1 demonstrated its structural similarity to Re-1. Complexes Re-1 and 99 Tc-1 display selective binding affinity for amyloid plaques as evidenced by fluorescence spectroscopy, whereas the biodistribution data of 99m Tc-1Ϫcharacterized by relatively low brain uptake, fast clearance from brain and blood, and in vivo sta-bilityϪare considered encouraging for further elaboration on the structural features of 1 in the direction of increased brain uptake.Aβ plaques in living brain tissue [7][8][9] and demonstrated the potential utility of these agents. The most widely studied PET amyloid imaging agent is the 2-phenylbenzothiazole derivative 2-(4Ј-[ 11 C]methylaminophenyl)-6-hydroxybenzothiazole (Pittsburgh compound-B, [ 11 C]PiB), a neutral derivative of the amyloid binding dye thioflavin-T (Scheme 1) that is employed in clinical practice. The histological and Scheme 1. Structures of thioflavin T, Pittsburg compound B (PiB), and complex 1.www.eurjic.org